Latest filing published 18 Mar 2025 for Kalaris Therapeutics, Inc..
No signal scores available.
Samir Chandrakant Patel has filed trades across 2 companies (mainly through SEC (Form 4)), most often in IVERIC bio, Inc. and Kalaris Therapeutics, Inc. In total, 138 filings cover trades dated from 23 September 2013 to 18 March 2025.
Sales make up the whole of the open-market record (86 sales, €24.9M). Outside the open market, there are 2 share grants and 44 option exercises.
On 18 March 2025 came the latest disclosure, a share grant in Kalaris Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations